Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2022 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-3341405 ( ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C., 20549 FORM 10-K _____________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ___________________ Commission File Number: 001-35020 ______________________ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Delaware 20-3341405 (State or Other Jurisdiction of Incorporation or Organization) for the transition period from _____ to _____ (I.R.S. Employer Identification No.) Commission File Number: 001-35020 x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 INFUSYSTEM HOLDINGS, INC. 3851 ...

InfuSystem Holdings Inc. (NYSE:INFU) Q3 2021 Earnings Conference Call November 15, 2021 9:00 AM ET Company Participants Joe Dorame - IR, Lytham Partners Richard DiIorio - CEO Carrie Lachance - President and COO Barry Steele - CFO Conference Call Participants Alexander Nowak - Craig-Hallum Brooks O'Neil - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Aaron Warwick - Breakout Investors Operator Good day and welcome to the InfuSystem Holdings, Inc. Third Quarter 2021 Earnings Conference Call. All p ...

Table of Contents ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2021 or (Exact name of registrant as specified in its charter) Delaware 20-3341405 (S ...

InfuSystem Holdings Inc. (NYSE:INFU) Q2 2021 Results Conference Call August 12, 2021 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich DiIorio - Chief Executive Officer Carrie Lachance - President and Chief Operating Officer Barry Steele - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Douglas Weiss - DSW Investment Aaron Warwick - ES Capital Operator Good day, and welc ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2021 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-3341405 (State or Oth ...

InfuSystem Holdings Inc. (NYSE:INFU) Q1 2021 Earnings Conference Call May 6, 2021 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich DiIorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Trent McCarthy - Craig-Hallum Frank Takkinen - Lake Street Jim Sidoti - Sidoti & Company James Terwilliger - Northland Securities Doug Weiss - DSW Investments Operator Good day, ladies and gentlemen and ...

Enabling Continuity of Care for Patients, From the Clinic to Their Home Investor Presentation March 2021 l (NYSE American: INFU) Forward-Looking Statement / Non-GAAP Measures Forward-Looking Statement Certain statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, business plans, objectives and prospec ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C., 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ___________________ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (St ...